omeprazole and Barrett Epithelium studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Research Excerpts

Excerpt	Relevance	Reference
" However, little is known about the effect of omeprazole on duodenogastric reflux (DGR) and duodenogastro-oesophageal reflux (DGOR)."	9.08	Effect of omeprazole 20 mg twice daily on duodenogastric and gastro-oesophageal bile reflux in Barrett's oesophagus. ( Anggiansah, A; Manifold, DK; Marshall, RE; Owen, WA; Owen, WJ, 1998)
"Twenty-five patients with systemic sclerosis and severe gastro-oesophageal reflux disease were treated with 20-80 mg omeprazole daily for up to 5 years."	9.07	Omeprazole in the long-term treatment of severe gastro-oesophageal reflux disease in patients with systemic sclerosis. ( Hage, E; Hendel, J; Hendel, L; Stentoft, P, 1992)
"The purpose of this study was to assess whether adequate intra-esophageal acid suppression could be achieved with once daily versus twice daily omeprazole in patients with gastroesophageal specialized intestinal metaplasia (GEJSIM), short-segment (SSBE) and long-segment Barrett's esophagus (LSBE)."	7.79	The dose of omeprazole required to achieve adequate intraesophageal acid suppression in patients with gastroesophageal junction specialized intestinal metaplasia and Barrett's esophagus. ( Bassett, JT; Horwhat, JD; Maydonovitch, CL; Moawad, FJ; Veerappan, GR; Watson, JT; Wong, RK, 2013)
" We report data from patients with refractory reflux esophagitis who were undergoing maintenance therapy with >/=20 mg omeprazole daily for a mean period of 6."	7.70	Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa. ( Dent, J; Frame, MH; Havu, N; Klinkenberg-Knol, EC; Lloyd, D; Mitchell, B; Nelis, F; Prichard, P; Romàn, J; Snel, P; Walan, A, 2000)
"Three women and three men developed fundic gland polyps after 1-5 yr of omeprazole therapy, 20 mg/day."	7.69	Fundic gland polyps developing during omeprazole therapy. ( el-Zimaity, HM; Graham, DY; Jackson, FW, 1997)
"In patients with Barrett's esophagus, LES pressure was considerably lower and percentage exposure to acid was considerably higher than in either patients with esophagitis or controls (p less than 0."	5.28	Effect of omeprazole on gastroesophageal reflux in Barrett's esophagus. ( Farroni, F; Fiorucci, S; Morelli, A; Pelli, MA; Santucci, L, 1989)
"Forty-five patients with long segment Barrett esophagus were treated in a randomized 2-year follow-up study with either omeprazole 40 mg b."	5.09	Effect of elimination of acid reflux on epithelial cell proliferative activity of Barrett esophagus. ( de Jager-Krikken, A; Ganesh, S; Karrenbeld, A; Kleibeuker, JH; Klinkenberg-Knol, EC; Kuipers, EJ; Lamers, CB; Peters, FT; Sluiter, WJ, 2000)
" However, little is known about the effect of omeprazole on duodenogastric reflux (DGR) and duodenogastro-oesophageal reflux (DGOR)."	5.08	Effect of omeprazole 20 mg twice daily on duodenogastric and gastro-oesophageal bile reflux in Barrett's oesophagus. ( Anggiansah, A; Manifold, DK; Marshall, RE; Owen, WA; Owen, WJ, 1998)
"Twenty-five patients with systemic sclerosis and severe gastro-oesophageal reflux disease were treated with 20-80 mg omeprazole daily for up to 5 years."	5.07	Omeprazole in the long-term treatment of severe gastro-oesophageal reflux disease in patients with systemic sclerosis. ( Hage, E; Hendel, J; Hendel, L; Stentoft, P, 1992)
" The newest PPI, esomeprazole, brings a statistically significant increase in healing of mucosal injury and symptom relief in patients with erosive esophagitis, compared with omeprazole and lansoprazole."	4.81	Pharmacologic management of gastroesophageal reflux disease. ( Katz, PO; Ramakrishnan, A, 2002)
"The purpose of this study was to assess whether adequate intra-esophageal acid suppression could be achieved with once daily versus twice daily omeprazole in patients with gastroesophageal specialized intestinal metaplasia (GEJSIM), short-segment (SSBE) and long-segment Barrett's esophagus (LSBE)."	3.79	The dose of omeprazole required to achieve adequate intraesophageal acid suppression in patients with gastroesophageal junction specialized intestinal metaplasia and Barrett's esophagus. ( Bassett, JT; Horwhat, JD; Maydonovitch, CL; Moawad, FJ; Veerappan, GR; Watson, JT; Wong, RK, 2013)
"To determine control of oesophageal reflux using Bravo pH monitoring in patients BE on omeprazole-sodium bicarbonate oral suspension powder (Ome-NaBic) 40 mg twice daily."	3.78	Control of intra-oesophageal pH in patients with Barrett's oesophagus on omeprazole-sodium bicarbonate therapy. ( Bleker, WF; Gerson, LB; Mitra, S; Yeung, P, 2012)
" We administered high-dose omeprazole to patients with Barrett's esophagus for 2 years, and investigated changes in gastric ECL (Enterochromaffin-like) cells using endoscopic biopsy specimens to clarify the etiology of hyperplasia of the parietal cells."	3.73	Changes in gastric ECL cells and parietal cells after long-term administration of high-dose omeprazole to patients with Barrett's esophagus. ( Makuuchi, H; Nishi, T; Weinstein, WM, 2005)
" We report data from patients with refractory reflux esophagitis who were undergoing maintenance therapy with >/=20 mg omeprazole daily for a mean period of 6."	3.70	Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa. ( Dent, J; Frame, MH; Havu, N; Klinkenberg-Knol, EC; Lloyd, D; Mitchell, B; Nelis, F; Prichard, P; Romàn, J; Snel, P; Walan, A, 2000)
"The case of an intramucosal adenocarcinoma diagnosed 18 months after apparently complete squamous re-epithelialisation achieved using argon plasma coagulation and high dose omeprazole (40 mg/daily) is reported in a 68 year old patient presenting initially with a Barrett's oesophagus without dysplasia."	3.70	Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett's oesophagus. ( Cremer, M; Devière, J; Peny, MO; Salmon, I; Van Laethem, JL, 2000)
" Seventeen patients with apparently complete endoscopic and histological eradication of Barrett's oesophagus were re-evaluated at one year; eight (47%) disclosed relapsing islands of Barrett metaplasia despite continuous omeprazole therapy (10-40 mg/day)."	3.70	Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: immediate and mid term results. ( Cremer, M; Delhaye, M; Devière, J; Peny, MO; Van Laethem, JL, 1998)
"Three women and three men developed fundic gland polyps after 1-5 yr of omeprazole therapy, 20 mg/day."	3.69	Fundic gland polyps developing during omeprazole therapy. ( el-Zimaity, HM; Graham, DY; Jackson, FW, 1997)
" In this case report, a patient with Barrett's oesophagus complicated by high grade dysplasia and focal adenocarcinoma was treated by Nd:Yag laser then high dose rate intraluminal irradiation while on omeprazole 40 mg/day."	3.69	[Partial regression of Barret esophagus with high grade dysplasia and adenocarcinoma after photocoagulation and endocurietherapy under antisecretory treatment]. ( Bouché, O; Demange, L; Diébold, MD; Fremond, L; Thiefin, G; Zeitoun, P, 1995)
"Four of five patients showed persistent abnormal gastroesophageal reflux after treatment with omeprazole."	3.69	Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus. ( Castell, DO; Katzka, DA, 1994)
"Prevalence of newly identified Barrett's esophagus was 14 % with half diagnosed only after treatment."	2.80	Once-daily omeprazole/sodium bicarbonate heals severe refractory reflux esophagitis with morning or nighttime dosing. ( Achem, SR; Adamson, SC; Alexander, JA; Arora, AS; Crowell, MD; Dabade, TS; DeJesus, RS; Diehl, NN; Enders, FT; Francis, DL; Fredericksen, M; Geno, DM; Houston, MS; Jung, KW; Katzka, DA; Lohse, M; Majka, AJ; Murray, JA; Namasivayam, V; O'Neil, AE; Orbelo, DM; Romero, Y, 2015)
" dosing of rabeprazole."	2.71	Lack of predictors of normalization of oesophageal acid exposure in Barrett's oesophagus. ( Hall, M; Higbee, A; Mathur, S; Sampliner, RE; Sharma, P; Wani, S; Weston, AP, 2005)
"Endoscopic ablation of Barrett's esophagus has been described in which various thermocoagulation modalities are used in combination with a high dose of a proton pump inhibitor."	2.71	Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett's esophagus. ( Cortina, G; Dulai, GS; Fontana, L; Ippoliti, A; Jensen, DM, 2005)
"39 patients with Barrett's esophagus, seven of them with low-grade dysplasia, underwent APC and received 40 mg omeprazole daily for eradication of the metaplastic epithelium."	2.70	Long-term follow-up and factors predictive of recurrence in Barrett's esophagus treated by argon plasma coagulation and acid suppression. ( Cremer, M; Devière, J; Kahaleh, M; Nagy, N; Van Laethem, JL, 2002)
"Patients with Barrett's esophagus of 2-6 cm in length were treated with omeprazole (40 mg b."	2.70	Impact of esophageal acid exposure on the endoscopic reversal of Barrett's esophagus. ( Camargo, L; Fass, R; Sampliner, RE, 2002)
" The aim of this prospective study was to assess the efficacy of argon plasma coagulation in combination with high-dose omeprazole therapy to ablate nondysplastic Barrett's epithelium."	2.69	Ablation of Barrett's epithelium by endoscopic argon plasma coagulation in combination with high-dose omeprazole. ( Antos, D; Bayerdörffer, E; Miehlke, S; Schentke, KU; Schulz, H; Stolte, M; Vieth, M, 2000)
"Omeprazole treatment resulted in a decrease of acid reflux per 24 h from 23."	2.69	The influence of Helicobacter pylori on oesophageal acid exposure in GERD during acid suppressive therapy. ( Ganesh, S; Kleibeuker, JH; Klinkenberg-Knol, EC; Kuipers, EJ; Lamers, CB; Peters, FT; Sluiter, WJ, 1999)
"Treatment with omeprazole 20-80 mg over 1-3 years has yielded conflicting but largely disappointing results."	2.69	Continuous treatment with omeprazole 20 mg daily for up to 6 years in Barrett's oesophagus. ( Cooper, BT; Cox, MA; Iqbal, TH; Neumann, CS, 1998)
"KTP laser destruction of Barrett's esophagus induced mucosal regeneration with normal squamous cell epithelium in combination with acid suppression."	2.69	KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus. ( Ell, C; Gossner, L; Hahn, EG; May, A; Seitz, G; Stolte, M, 1999)
"However, recent work suggests that duodenogastric reflux (DGR) may be reduced by omeprazole."	2.69	Effect of omeprazole on antral duodenogastric reflux in Barrett oesophagus. ( Anggiansah, A; Manifold, DK; Marshall, RE; Owen, WJ, 2000)
"The term Barrett's esophagus refers to a premalignant condition that is characterized by the replacement of the esophageal squamous mucosa by a columnar-lined one."	2.69	High power setting argon plasma coagulation for the eradication of Barrett's esophagus. ( Blaya, C; Busnello, JV; Lopes, CV; Pereira-Lima, JC; Rynkowski, CB; Saul, C; Toneloto, EB, 2000)
" Another group of 17 patients with Barrett's oesophagus was treated with an H2-receptor antagonist in standard dosage for 12-36 (mean 23) months."	2.68	Long term continuous omeprazole treatment of patients with Barrett's oesophagus. ( Cooper, BT; Iqbal, TH; Neumann, CS, 1995)
"Patients with Barrett's esophagus at least 3 cm long and with specialized columnar epithelium were treated with 60 mg of lansoprazole each morning."	2.67	Effect of up to 3 years of high-dose lansoprazole on Barrett's esophagus. ( Sampliner, RE, 1994)
"Gastroesophageal reflux disease (GERD) is defined by recurrent and troublesome heartburn and regurgitation or GERD-specific complications and affects approximately 20% of the adult population in high-income countries."	2.66	Gastroesophageal Reflux Disease: A Review. ( Lagergren, J; Maret-Ouda, J; Markar, SR, 2020)
"To review the literature on the treatment of gastroesophageal reflux disease (GERD) with emphasis on pharmacological aspects."	2.43	Treatment of gastroesophageal reflux disease. ( Camargos, PA; Guimarães, EV; Marguet, C, 2006)
"The treatment of Barrett's esophagus is controversial."	2.43	[The clinical strategy for the Barrett's esophagus]. ( Goto, H; Kitabatake, S; Niwa, Y, 2005)
" Methods to optimize nocturnal acid control include careful attention to dosing schedule, using higher doses of PPIs, adding an histamine H2-receptor antagonist at bedtime to once or twice daily delayed-release PPI, or using immediate-release omeprazole (Zegerid powder for oral suspension; Santarus, Inc."	2.43	Review article: putting immediate-release proton-pump inhibitors into clinical practice--improving nocturnal acid control and avoiding the possible complications of excessive acid exposure. ( Katz, PO, 2005)
"The length of the Barrett's esophagus segment and the size of a hiatal hernia are associated with the risk of developing high-grade dysplasia and esophageal adenocarcinoma."	2.42	Reflux disease and Barrett's esophagus. ( Haag, S; Holtmann, G, 2003)
" Physiologic factors that may contribute to a poor response to these drugs include the considerable variation in the bioavailability of PPIs, the need to take PPIs with meals, the influence of Helicobacter pylori-associated gastritis, and genetic variation in enzyme capacity, resulting in rapid and slow metabolizers of PPIs."	2.42	Medical management of patients with esophageal or supraesophageal gastroesophageal reflux disease. ( Richter, JE, 2003)
"Short-segment Barrett's esophagus is now clearly associated with an increased risk of dysplasia or cancer compared to intestinal metaplasia of the cardia, and the cancer risk in this condition is similar to that with long-segment Barrett's esophagus."	2.41	Gastroesophageal reflux disease and Barrett's esophagus. ( Falk, GW, 2001)
"Gastroesophageal reflux (GER) occurs in 2 distinct forms that differ in pathophysiology, clinical presentation, natural history, and therapy: mild GER (with no or minimal esophagitis) and classic, severe reflux (at risk for erosive esophagitis)."	2.40	Gastroesophageal reflux: practical management of a common, challenging disorder. ( Fass, R; Soll, AH, 1999)
"Endoscopic ablation therapy of Barrett's esophagus remains experimental until reversal has been documented over a longer period of time and criteria are validated to select appropriate candidates at high risk of developing adenocarcinoma of the esophagus."	2.40	Ablation of Barrett's mucosa. ( Sampliner, RE, 1997)
"pylori and GERD and its potential implications for the management of GERD."	2.40	Review article: Helicobacter pylori and gastro-oesophageal reflux disease-clinical implications and management. ( O'Connor, HJ, 1999)
"36), we did not find a dose-response relationship with PPI duration (P trend = 0."	1.48	Acid suppression medications reduce risk of oesophageal adenocarcinoma in Barrett's oesophagus: a nested case-control study in US male veterans. ( El-Serag, HB; Tan, MC; Thrift, AP; Yu, X, 2018)
"Gastroesophageal reflux is a well-recognized complication of obesity."	1.35	Case reports--resolution of Barrett's disease and esophageal epithelial atypia after gastric bypass and LAP-BAND. ( Chang, CG; Perez, E, 2009)
"Thirty-two patients with long-segment Barrett esophagus who were asymptomatic with PPIs."	1.32	Persistent acid and bile reflux in asymptomatic patients with Barrett esophagus receiving proton pump inhibitor therapy. ( Casey, JF; Clark, GW; Guillou, PJ; Hick, DG; Sarela, AI; Verbeke, CS, 2004)
"To assess both acid gastro-oesophageal reflux (GOR) suppression in patients with Barrett's oesophagus on proton-pump inhibitors (PPI) and the predictive value of symptoms."	1.31	Persistent acid reflux and symptoms in patients with Barrett's oesophagus on proton-pump inhibitor therapy. ( Bale, R; Basu, KK; de Caestecker, JS; West, KP, 2002)
"Both acid and bile reflux is significantly suppressed by proton pump inhibitor therapy with exceptions among individual esophagitis patients."	1.31	Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy. ( Menges, M; Müller, M; Zeitz, M, 2001)
" This is a multicenter trial defining the efficacy and safety of multipolar electrocoagulation combined with high-dose acid inhibition."	1.31	Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study. ( Faigel, D; Fennerty, MB; Ippoliti, A; Lewin, K; Lieberman, D; Sampliner, RE; Weinstein, WM, 2001)
"Gastroesophageal reflux disease has a multifactorial etiology."	1.31	Efficacy of medical therapy and antireflux surgery to prevent Barrett's metaplasia in patients with gastroesophageal reflux disease. ( Gadenstaetter, M; Klaus, A; Klingler, PJ; Obrist, P; Profanter, C; Weiss, H; Wetscher, GJ; Wykypiel, H, 2001)
"Patients with Barrett's esophagus were treated with omeprazole (40 mg by mouth, twice daily) and underwent selective multipolar electrocoagulation of the metaplastic segment monthly until complete squamous re-epithelialization or a maximum of 6 treatments was achieved."	1.31	Effect of multipolar electrocoagulation on EUS findings in Barrett's esophagus. ( Faigel, DO; Fanning, S; Fennerty, MB; Lieberman, DA; Sampliner, RB; Weinstein, WM, 2002)
"Strategies to prevent Barrett's-related esophageal cancer have focused on reversal of Barrett's using pharmacological or surgical antireflux therapies and endoscopically-induced injury."	1.31	Does chemoprevention of Barrett's esophagus using acid suppression and/or COX-2 inhibition prevent neoplastic progression? ( Fennerty, MB, 2002)
"Patients with Barrett's esophagus who agreed to undergo ablation of Barrett's epithelium by using multipolar electrocoagulation were included."	1.31	Preferential repair by squamous epithelium of thermal induced injury to the proximal stomach in patients undergoing ablation of Barrett's esophagus. ( Fass, R; Garewal, HS; Hayden, CW; Ramsey, L; Sampliner, RE, 2001)
"26 patients with a Barrett's esophagus of at least 2 cm length (medium 4."	1.30	[Treatment of Barrett esophagus with argon plasma coagulation with acid suppression--a prospective study]. ( Jakobs, R; Maass, S; Martin, WR; Riemann, JF; Spiethoff, A, 1999)
"Endoscopic reversal of Barrett's esophagus with multipolar electrocoagulation and high-dose omeprazole has been previously described but long-term results are not available."	1.30	Durability of new squamous epithelium after endoscopic reversal of Barrett's esophagus. ( Bhattacharyya, A; Garewal, HS; Sampliner, RE; Sharma, P, 1999)
"Argon plasma coagulation in an acid-controlled environment was both efficacious and safe in the treatment of Barrett's esophagus."	1.30	The efficacy and safety of argon plasma coagulation therapy in Barrett's esophagus. ( Grade, AJ; Medlin, SM; Ramirez, FC; Shah, IA, 1999)
" The two groups were not different in regard to their symptom frequency and severity before therapy, amount of lansoprazole dosage required to eliminate symptoms, length of Barrett's metaplasia, presence of hiatal hernia, lower esophageal sphincter resting tone and length, or esophageal peristaltic function."	1.30	Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal acid reflux in patients with Barrett's esophagus. ( Ouatu-Lascar, R; Triadafilopoulos, G, 1998)
"Endoscopic ablation of Barrett's esophagus, including associated dysplasia and adenocarcinoma, can be achieved by various techniques, but few long-term results are available."	1.30	Laser and multipolar electrocoagulation ablation of early Barrett's adenocarcinoma: long-term follow-up. ( Bhattacharyya, A; Jaffe, PE; Sampliner, RE; Sharma, P, 1999)
"Cytology from Barrett's esophagus can be misleading in the presence of severe inflammation."	1.30	Brush cytology in the diagnosis of neoplasia in Barrett's esophagus. ( Alderson, D; Hardwick, RH; Lott, M; Morgan, RJ; Warren, BF, 1997)
"Patients with at least 2 cm of Barrett's esophagus were treated with omeprazole, and half the circumference of the Barrett's was treated with multipolar electrocoagulation (MPEC); the other half served as an internal control."	1.29	Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: preliminary results. ( Fennerty, B; Garewal, HS; Sampliner, RE, 1996)
"Thirty-six patients with Barrett's esophagus and dysplasia were treated with photodynamic therapy, and sodium porfimer 2."	1.29	Photodynamic therapy for Barrett's esophagus: clinical update. ( Overholt, BF; Panjehpour, M, 1996)
"Ten white men with Barrett's esophagus received 40 mg of omeprazole daily."	1.29	Restoration of squamous mucosa after ablation of Barrett's esophageal epithelium. ( Berenson, MM; Buchi, KN; Johnson, TD; Markowitz, NR; Samowitz, WS, 1993)
"Barrett's esophagus is mainly regarded as an acquired condition related to increased gastroesophageal reflux."	1.29	Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole. ( Belicchi, M; Bocchia, P; Franceschi, M; Lapertosa, G; Malesci, A; Mela, GS; Ronchi, G; Savarino, V; Zentilin, P, 1996)
"In this case report, a patient with Barrett's esophagus of stable length had half the circumference of the Barrett's epithelium ablated with laser therapy while on a high-dose proton-pump inhibitor."	1.29	Regression of Barrett's esophagus by laser ablation in an anacid environment. ( Fennerty, MB; Garewal, HS; Hixson, LJ; Sampliner, RE, 1993)
"In patients with Barrett's esophagus, LES pressure was considerably lower and percentage exposure to acid was considerably higher than in either patients with esophagitis or controls (p less than 0."	1.28	Effect of omeprazole on gastroesophageal reflux in Barrett's esophagus. ( Farroni, F; Fiorucci, S; Morelli, A; Pelli, MA; Santucci, L, 1989)

Research

Studies (160)

Authors

Clinical Trials (20)

Trial Overview

Trial Outcomes

Depth of Injury

Timeframe	Studies, this research(%)	All Research%
pre-1990	5 (3.13)	18.7374
1990's	69 (43.13)	18.2507
2000's	70 (43.75)	29.6817
2010's	13 (8.13)	24.3611
2020's	3 (1.88)	2.80

Authors	Studies
Szachnowicz, S	1
Duarte, AF	1
Nasi, A	1
da Rocha, JRM	1
Seguro, FB	1
Bianchi, ET	1
Tustumi, F	1
de Moura, EGH	1
Sallum, RAA	1
Cecconello, I	1
Wronska, E	1
Polkowski, M	1
Orlowska, J	1
Mroz, A	1
Wieszczy, P	1
Regula, J	1
Maret-Ouda, J	1
Markar, SR	1
Lagergren, J	1
Tan, MC	1
El-Serag, HB	1
Yu, X	1
Thrift, AP	1
Huang, J	1
Liu, H	1
Sun, T	1
Fang, JY	1
Wang, J	1
Xiong, H	1
Watson, JT	1
Moawad, FJ	1
Veerappan, GR	1
Bassett, JT	1
Maydonovitch, CL	1
Horwhat, JD	2
Wong, RK	1
Orbelo, DM	1
Enders, FT	1
Romero, Y	1
Francis, DL	1
Achem, SR	1
Dabade, TS	1
Crowell, MD	1
Geno, DM	1
DeJesus, RS	1
Namasivayam, V	1
Adamson, SC	1
Arora, AS	1
Majka, AJ	1
Alexander, JA	1
Murray, JA	1
Lohse, M	1
Diehl, NN	1
Fredericksen, M	1
Jung, KW	1
Houston, MS	1
O'Neil, AE	1
Katzka, DA	4
Babic, Z	1
Bogdanovic, Z	1
Dorosulic, Z	1
Petrovic, Z	1
Kujundzic, M	1
Banic, M	1
Marusic, M	1
Heinzl, R	1
Bilić, B	1
Andabak, M	1
Emken, BG	1
Lundell, LR	1
Wallin, L	1
Myrvold, HE	1
Engström, C	1
Montgomery, M	1
Malm, AR	1
Lind, T	1
Hatlebakk, JG	1
Koak, Y	1
Davies, SE	1
Winslet, M	1
Bronner, MP	2
Overholt, BF	7
Taylor, SL	1
Haggitt, RC	1
Wang, KK	4
Burdick, JS	2
Lightdale, CJ	2
Kimmey, M	2
Nava, HR	2
Sivak, MV	2
Nishioka, N	2
Barr, H	5
Canto, MI	1
Marcon, N	2
Pedrosa, M	2
Grace, M	2
Depot, M	2
Pellicano, R	1
Wong, H	1
Yau, T	1
Chan, P	1
Ng, IO	1
Chan, G	1
Hui, P	1
Law, WL	1
Lo, CM	1
Hedley, AJ	1
Epstein, RJ	1
Jankowski, J	2
Attwood, S	1
deCaestecker, J	1
Chang, CG	1
Perez, E	1
Sharma, P	6
Triadafilopoulos, G	4
Lombard, CM	1
Jobe, BA	1
Lord, RV	1
Onuchina, EV	1
Tsukanov, VV	1
Osipenko, MF	1
Gerson, LB	2
Mitra, S	1
Bleker, WF	1
Yeung, P	1
Inadomi, JM	1
Miyashita, T	1
Shah, FA	1
Harmon, JW	1
Marti, GP	1
Matsui, D	1
Okamoto, K	1
Makino, I	1
Hayashi, H	1
Oyama, K	1
Nakagawara, H	1
Tajima, H	1
Fujita, H	1
Takamura, H	1
Murakami, M	1
Ninomiya, I	1
Kitagawa, H	1
Fushida, S	1
Fujimura, T	1
Ohta, T	1
Basu, KK	3
Pick, B	1
Bale, R	2
West, KP	2
de Caestecker, JS	3
Kahaleh, M	1
Van Laethem, JL	4
Nagy, N	1
Cremer, M	4
Devière, J	5
Fennerty, MB	5
Haag, S	1
Holtmann, G	1
Parrilla, P	2
Martínez de Haro, LF	2
Ortiz, A	2
Munitiz, V	2
Molina, J	2
Bermejo, J	2
Canteras, M	1
Ackroyd, R	2
Kelty, CJ	1
Brown, NJ	2
Stephenson, TJ	2
Stoddard, CJ	2
Reed, MW	2
Vakil, N	1
Panjehpour, M	5
Halberg, DL	1
Richter, JE	1
Füessl, HS	2
Sarela, AI	1
Hick, DG	1
Verbeke, CS	1
Casey, JF	1
Guillou, PJ	1
Clark, GW	1
Moayyedi, P	1
Dent, J	2
Talley, NJ	1
Dulai, GS	1
Jensen, DM	1
Cortina, G	1
Fontana, L	1
Ippoliti, A	3
Todd, JA	2
Shetler, K	1
Kitabatake, S	1
Niwa, Y	1
Goto, H	1
Nishi, T	1
Makuuchi, H	1
Weinstein, WM	3
Wani, S	1
Sampliner, RE	14
Weston, AP	1
Mathur, S	1
Hall, M	1
Higbee, A	1
Johnston, MH	1
Eastone, JA	1
Cartledge, J	1
Mathews, JS	1
Foggy, JR	1
Katz, PO	5
Rossi, M	1
Barreca, M	1
de Bortoli, N	1
Renzi, C	1
Santi, S	1
Gennai, A	1
Bellini, M	1
Costa, F	1
Conio, M	1
Marchi, S	1
Cooper, BT	3
Chapman, W	1
Neumann, CS	3
Gearty, JC	1
Burns, RB	1
Guimarães, EV	1
Marguet, C	1
Camargos, PA	1
Diaz-Cervantes, E	1
De-la-Torre-Bravo, A	1
Spechler, SJ	1
Torres-Durazo, E	1
Sobrino-Cossio, S	1
Martínez-Carrillo, O	1
Gamboa-Robles, J	1
Bozymski, EM	2
Quigley, EM	1
McBride, MA	1
Vanagunas, AA	1
Breshnahan, JP	1
Barch, DB	1
Laukka, MA	1
Brandt, LJ	1
Blansky, RL	1
Kauvar, DR	1
Collen, MJ	2
Strong, RM	2
Fremond, L	1
Bouché, O	1
Diébold, MD	1
Demange, L	1
Zeitoun, P	1
Thiefin, G	1
Savarino, V	2
Mela, GS	2
Zentilin, P	2
Celle, G	1
Vigneri, S	1
Fuchs, KH	1
Engemann, R	1
Thiede, A	1
Scott, LD	1
Sellin, JH	1
Le Rhun, M	1
Galmiche, JP	1
Castell, DO	6
Klinkenberg-Knol, EC	5
Festen, HP	1
Jansen, JB	1
Lamers, CB	4
Nelis, F	2
Snel, P	2
Lückers, A	1
Dekkers, CP	1
Havu, N	2
Meuwissen, SG	1
Jerome-Zapadka, KM	1
Clarke, MR	1
Sekas, G	1
Gore, S	2
Healey, CJ	1
Sutton, R	1
Eyre-Brook, IA	1
Gear, MW	1
Shepherd, NA	2
Wilkinson, SP	2
Hassall, E	2
Hixson, LJ	1
Garewal, HS	6
Berenson, MM	1
Johnson, TD	1
Markowitz, NR	1
Buchi, KN	1
Samowitz, WS	1
Iqbal, TH	2
Ertan, A	1
Zimmerman, M	1
Younes, M	1
McDougall, NI	1
Johnston, BT	1
Kee, F	1
Collins, JS	1
McFarland, RJ	1
Love, AH	1
Weber, L	1
Luman, W	1
Lessels, AM	1
Palmer, KR	1
Komorowski, RA	1
Hogan, WJ	1
Chausow, DD	1
Fennerty, B	1
Song, MW	1
Malesci, A	1
Belicchi, M	1
Lapertosa, G	1
Bocchia, P	1
Ronchi, G	1
Franceschi, M	1
Krueger, KJ	1
DiPalma, JA	1
Morgan, GP	1
Sontag, SJ	1
Schnell, TG	1
Chejfec, G	1
Kurucar, C	1
Karpf, J	1
Levine, G	1
Shaheen, NJ	1
Camargo, E	1
Wetscher, GJ	2
Profanter, C	2
Gadenstätter, M	1
Perdikis, G	1
Glaser, K	1
Hinder, RA	1
Fass, R	6
Yalam, JM	1
Camargo, L	3
Johnson, C	1
el-Zimaity, HM	1
Jackson, FW	1
Graham, DY	1
Hardwick, RH	1
Morgan, RJ	1
Warren, BF	1
Lott, M	1
Alderson, D	1
Ouatu-Lascar, R	2
Lee, JM	1
O'Morain, CA	1
Cox, MA	1
Israel, DM	1
Marshall, RE	2
Anggiansah, A	2
Manifold, DK	2
Owen, WA	1
Owen, WJ	2
Peny, MO	2
Delhaye, M	1
Blustein, PK	1
Beck, PL	1
Meddings, JB	1
Van Rosendaal, GM	1
Bailey, RJ	1
Lalor, E	1
Thomson, AB	1
Verhoef, MJ	1
Sutherland, LR	1
Gossner, L	1
May, A	1
Stolte, M	3
Seitz, G	1
Hahn, EG	1
Ell, C	1
Haydek, JM	1
Pace, F	1
Bianchi Porro, G	1
O'Connor, HJ	1
Jaffe, PE	1
Bhattacharyya, A	2
Peters, FT	3
Kuipers, EJ	3
Ganesh, S	3
Sluiter, WJ	3
Kleibeuker, JH	3
Grade, AJ	1
Shah, IA	1
Medlin, SM	1
Ramirez, FC	1
Fitzgerald, RC	1
Biddlestone, L	1
Garewal, H	1
Ramsey, L	2
Kraus, K	1
Sampliner, R	1
Martin, WR	1
Jakobs, R	1
Spiethoff, A	1
Maass, S	1
Riemann, JF	1
Kochman, ML	1
Soll, AH	1
Salmon, I	1
Mitchell, B	1
Prichard, P	1
Lloyd, D	1
Frame, MH	1
Romàn, J	1
Walan, A	1
Malagon, IB	1
Hayden, CW	2
Wendel, CS	1
Schulz, H	1
Miehlke, S	1
Antos, D	1
Schentke, KU	1
Vieth, M	2
Bayerdörffer, E	1
Pereira-Lima, JC	1
Busnello, JV	1
Saul, C	1
Toneloto, EB	1
Lopes, CV	1
Rynkowski, CB	1
Blaya, C	1
Sauer, J	1
Junginger, T	1
Armstrong, D	1
Davis, MF	1
Marcus, SL	1
Johnson, AG	1
Ofman, JJ	1
Lewin, K	2
Ramers, C	1
Lieberman, D	2
Weinstein, W	1
Schmitz, JM	1
Alexandridis, T	1
Seifert, E	1
Weston, T	1
MacDonald, TM	1
Johnston, DA	1
Dillon, JF	1
Karrenbeld, A	1
de Jager-Krikken, A	1
Menges, M	1
Müller, M	1
Zeitz, M	1
Falk, GW	1
Srinivasan, R	1
Ramakrishnan, A	2
Vela, MF	1
Faigel, D	1
Corless, CL	1
Sheppard, B	1
Faigel, DO	2
Lieberman, DA	2
Eisendrath, P	1
Gadenstaetter, M	1
Klingler, PJ	1
Weiss, H	1
Obrist, P	1
Wykypiel, H	1
Klaus, A	1
Fanning, S	1
Sampliner, RB	1
Tröger, U	1
Stötzel, B	1
Martens-Lobenhoffer, J	1
Gollnick, H	1
Meyer, FP	1
Lundell, L	1
Beker, JA	1
Herben, MG	1
Hendel, L	1
Hage, E	1
Hendel, J	1
Stentoft, P	1
Lajoie, C	1
Encinas Sotillos, A	1
Romero Ganuza, FJ	1
Hernández Navarrete, C	1
Cabrerizo Puente, A	1
Buset, M	1
Dumonceau, JM	1
Rickaert, F	1
Fiorucci, S	1
Santucci, L	1
Farroni, F	1
Pelli, MA	1
Morelli, A	1
Hameeteman, W	1
Tytgat, GN	1
Lee, FI	1
Isaacs, PE	1

Trial	Phase	Enrollment	Study Type	Start Date	Status
Argon Plasma Coagulation for Barrett's Esophagus With Low Grade Dysplasia: A Randomized Trial With Long Term Follow-up Evaluating the Impact of Power Setting and Proton Pump Inhibitor Dose[NCT04154748]		71 participants (Actual)	Interventional	2002-06-04	Completed
Evaluating Efficacy and Safety of Combined Thread Embedding and Auricular Acupuncture in Gastroesophageal Reflux Disease With Liver Qi Invading Stomach Pattern: A Randomized Controlled Trial[NCT06157424]		66 participants (Anticipated)	Interventional	2023-12-06	Recruiting
Evaluation of MicroRNA Expression in Blood and Cytology Specimens as a Novel Method for Detecting Barrett's Esophagus[NCT02464930]		220 participants (Anticipated)	Observational	2015-04-30	Recruiting
Endoscopic Resection or Ablation for Patients With Dysplasia or Intramucosal Cancer in Barrett's Esophagus[NCT01572987]		12 participants (Actual)	Interventional	2011-09-30	Terminated (stopped due to Recruitment goals not being met)
Evaluation of Performance Characteristics of Capsule Endoscopy With PillCam UGI Capsule Compared to Standard Endoscopy for Screening of Barrett's Esophagus: A Prospective Tandem Study[NCT03167970]		21 participants (Actual)	Observational	2017-05-03	Completed
CryoSpray Ablation(tm)Thoracic Patient Registry[NCT00785239]		0 participants (Actual)	Observational	2009-04-30	Withdrawn (stopped due to Business Reasons)
A Prospective, Multi-center, Longitudinal Cohort Study of CryoSpray Ablation of Low Grade or High Grade Dysplasia Within Barrett's Esophagus (LCS Dysplasia)[NCT00526786]	Phase 4	78 participants (Actual)	Interventional	2007-09-30	Terminated (stopped due to Business Reasons)
"A Pilot Study of the Safety, Efficacy, and Side Effects of Interventional Cryotherapy for the Eradication of Disease in the Pleural Space (ICE PLS)"[NCT00747916]	Phase 4	3 participants (Actual)	Interventional	2008-08-31	Terminated (stopped due to Business Reasons)
CryoSpray Ablation (TM) GI Patient Registry[NCT00747448]		199 participants (Actual)	Observational	2009-05-31	Completed
"Assessment of the Safety, Side Effects and Efficacy of Interventional Cryotherapy for the Eradication of Benign Airway Disease(ICE THE BAD)"[NCT00747461]	Phase 4	5 participants (Actual)	Interventional	2008-10-31	Terminated (stopped due to Business Reasons)
A Single Center Pilot Study of CryoSpray Ablation(TM) to Determine Safety and Feasibility in Radiation Induced Proctitis (CSA LGI-2)[NCT00756197]	Phase 4	0 participants (Actual)	Interventional	2008-10-31	Withdrawn (stopped due to Considering more robust design.)
A Multi-Center Study of CryoSpray Ablation(tm)in Malignant Airway Disease to Determine, Safety, and Tissue Effect in the Lung (ICE the MAD)[NCT00748085]		5 participants (Actual)	Interventional	2008-10-31	Terminated (stopped due to Business Reasons)
Cryotherapy Ablation of Barrett's Esophagus and Early Esophageal Cancer[NCT00321958]		23 participants (Actual)	Observational	2006-04-30	Terminated (stopped due to The sponsor determined that adequate data had been acquired.)
trūFreeze® Spray Cryotherapy Patient Registry[NCT01802203]		275 participants (Actual)	Observational [Patient Registry]	2013-04-30	Completed
A STUDY OF CRYOSPRAY ABLATIONTM USING SURGICAL RESECTION SPECIMENS TO DETERMINE TREATMENT EFFECT, DEPTH OF INJURY, AND SIDE EFFECTS IN THE ESOPHAGUS (CSA Depth 3)[NCT00754468]	Phase 4	7 participants (Actual)	Interventional	2009-02-28	Completed
A Phase II, Multi-Center Study of Interventional Spray Cryotherapy for Early-Stage Esophageal Cancer (ICE-CANCER)[NCT01868139]		1 participants (Actual)	Interventional	2013-06-30	Terminated (stopped due to insufficient accrual)
Proton Pump Inhibitors in the Prevention of Iron Reaccumulation in Patient With Hereditary Hemochromatosis[NCT01524757]		48 participants (Anticipated)	Interventional	2012-03-31	Not yet recruiting
Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective Study[NCT02081404]		98 participants (Actual)	Interventional	2009-03-01	Completed
Impact of Weight Loss on Gastroesophageal Reflux Disease in Overweight and Obese Subjects: a Prospective Study[NCT01574573]		52 participants (Actual)	Interventional	2009-06-30	Terminated (stopped due to Closed due to lack of recruitment)
Barrett's Esophagus Study (BEST) Trial - a Multi-Center and Endoscopic Outcomes Project[NCT00586404]		1,250 participants (Actual)	Observational	2007-11-30	Terminated (stopped due to lack of enrollment)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

histopathological findings analyzed to determine max depth of injury (mm) (NCT00754468)
Timeframe: End of Study

Intervention	millimeters (Mean)
Group 1: Cryo Spray Ablation	4.0
Group 2: Cryo Spray Ablation	5.2

Intervention	side effects (Number)
Group 1: Cryo Spray Ablation	2
Group 2: Cryo Spray Ablation	1

Article	Year
Gastroesophageal Reflux Disease: A Review. JAMA, 2020, 12-22, Volume: 324, Issue:24 Topics: Adenocarcinoma; Barrett Esophagus; Diagnosis, Differential; Esophageal Neoplasms; Fundoplication; Ga	2020
[Proton pump inhibitors, a family of drugs in continuous expansion]. Minerva gastroenterologica e dietologica, 2000, Volume: 46, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Inflammatory Agents, Non-Steroidal; Barrett E	2000
Clinical practice. Barrett's esophagus. The New England journal of medicine, 2009, Dec-24, Volume: 361, Issue:26 Topics: Adenocarcinoma; Algorithms; Barrett Esophagus; Esophageal Neoplasms; Esophagectomy; Esophagoscopy; E	2009
Clinical practice. Barrett's esophagus. The New England journal of medicine, 2009, Dec-24, Volume: 361, Issue:26 Topics: Adenocarcinoma; Algorithms; Barrett Esophagus; Esophageal Neoplasms; Esophagectomy; Esophagoscopy; E	2009
Clinical practice. Barrett's esophagus. The New England journal of medicine, 2009, Dec-24, Volume: 361, Issue:26 Topics: Adenocarcinoma; Algorithms; Barrett Esophagus; Esophageal Neoplasms; Esophagectomy; Esophagoscopy; E	2009
Clinical practice. Barrett's esophagus. The New England journal of medicine, 2009, Dec-24, Volume: 361, Issue:26 Topics: Adenocarcinoma; Algorithms; Barrett Esophagus; Esophageal Neoplasms; Esophagectomy; Esophagoscopy; E	2009
Clinical practice. Barrett's esophagus. The New England journal of medicine, 2009, Dec-24, Volume: 361, Issue:26 Topics: Adenocarcinoma; Algorithms; Barrett Esophagus; Esophageal Neoplasms; Esophagectomy; Esophagoscopy; E	2009
Clinical practice. Barrett's esophagus. The New England journal of medicine, 2009, Dec-24, Volume: 361, Issue:26 Topics: Adenocarcinoma; Algorithms; Barrett Esophagus; Esophageal Neoplasms; Esophagectomy; Esophagoscopy; E	2009
Clinical practice. Barrett's esophagus. The New England journal of medicine, 2009, Dec-24, Volume: 361, Issue:26 Topics: Adenocarcinoma; Algorithms; Barrett Esophagus; Esophageal Neoplasms; Esophagectomy; Esophagoscopy; E	2009
Clinical practice. Barrett's esophagus. The New England journal of medicine, 2009, Dec-24, Volume: 361, Issue:26 Topics: Adenocarcinoma; Algorithms; Barrett Esophagus; Esophageal Neoplasms; Esophagectomy; Esophagoscopy; E	2009
Clinical practice. Barrett's esophagus. The New England journal of medicine, 2009, Dec-24, Volume: 361, Issue:26 Topics: Adenocarcinoma; Algorithms; Barrett Esophagus; Esophageal Neoplasms; Esophagectomy; Esophagoscopy; E	2009
Does antireflux surgery prevent progression of Barrett's esophagus? Minerva chirurgica, 2011, Volume: 66, Issue:1 Topics: Adenocarcinoma; Barrett Esophagus; Cohort Studies; Combined Modality Therapy; Disease Progression; E	2011
Do proton pump inhibitors protect against cancer progression in GERD? Surgery today, 2013, Volume: 43, Issue:8 Topics: Adenocarcinoma; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Antioxidants; Barrett Esop	2013
Reflux disease and Barrett's esophagus. Endoscopy, 2003, Volume: 35, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Anti-Ulcer Agents; Barrett Esophagus; Endos	2003
Review article: test and treat or treat and test in reflux disease? Alimentary pharmacology & therapeutics, 2003, Volume: 17 Suppl 2 Topics: Adenocarcinoma; Ambulatory Care; Anti-Ulcer Agents; Barrett Esophagus; Esophageal Neoplasms; Gastroe	2003
Medical management of patients with esophageal or supraesophageal gastroesophageal reflux disease. The American journal of medicine, 2003, Aug-18, Volume: 115 Suppl 3A Topics: Age Factors; Barrett Esophagus; Female; Gastric Acid; Gastritis; Gastroesophageal Reflux; Gastrointe	2003
Clinical strategies -- interactive case discussions. Alimentary pharmacology & therapeutics, 2004, Volume: 20 Suppl 5 Topics: Anti-Ulcer Agents; Barrett Esophagus; Female; Heartburn; Humans; Male; Middle Aged; Omeprazole	2004
[The clinical strategy for the Barrett's esophagus]. Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Anti-Inflammatory Agents, Non-Steroidal; Ba	2005
Review article: putting immediate-release proton-pump inhibitors into clinical practice--improving nocturnal acid control and avoiding the possible complications of excessive acid exposure. Alimentary pharmacology & therapeutics, 2005, Volume: 22 Suppl 3 Topics: Adenocarcinoma; Barrett Esophagus; Chronotherapy; Delayed-Action Preparations; Disease Progression;	2005
Gastroesophageal reflux disease symptoms on antisecretory therapy: acid, non-acid, or no GERD. Reviews in gastroenterological disorders, 2006,Summer, Volume: 6, Issue:3 Topics: Aged; Anti-Ulcer Agents; Barrett Esophagus; Esophagitis, Peptic; Gastroesophageal Reflux; Humans; Ma	2006
Treatment of gastroesophageal reflux disease. Jornal de pediatria, 2006, Volume: 82, Issue:5 Suppl Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Adolescent; Adult; Anti-Ulcer Agents; Barre	2006
High-grade dysplasia in Barrett's oesophagus. The case against oesophageal resection. Annals of the Royal College of Surgeons of England, 2007, Volume: 89, Issue:6 Topics: Anti-Ulcer Agents; Barrett Esophagus; Endoscopy, Gastrointestinal; Esophageal Neoplasms; Esophagecto	2007
[Surgical or conservative therapy of Barrett esophagus?]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 1994, Volume: 65, Issue:2 Topics: Antacids; Barrett Esophagus; Esophageal Neoplasms; Esophagus; Follow-Up Studies; Gastroesophageal Re	1994
[Is remission of Barrett esophagus possible?]. Gastroenterologie clinique et biologique, 1994, Volume: 18, Issue:1 Pt 2 Topics: Antacids; Barrett Esophagus; Bethanechol Compounds; Cimetidine; Drug Therapy, Combination; Gastroeso	1994
Recurrent upper esophageal webs in association with heterotopic gastric mucosa: case report and literature review. The American journal of gastroenterology, 1994, Volume: 89, Issue:3 Topics: Aged; Barrett Esophagus; Deglutition Disorders; Esophagoscopy; Esophagus; Female; Follow-Up Studies;	1994
Barrett's esophagus: new definitions and approaches in children. Journal of pediatric gastroenterology and nutrition, 1993, Volume: 16, Issue:4 Topics: Adenocarcinoma; Adolescent; Adult; Aged; Barrett Esophagus; Child; Child, Preschool; Cimetidine; End	1993
Ablation of Barrett's mucosa. The Gastroenterologist, 1997, Volume: 5, Issue:3 Topics: Barrett Esophagus; Catheter Ablation; Combined Modality Therapy; Esophagoscopy; Humans; Laser Therap	1997
Different management for Helicobacter pylori positive and negative patients with gastro-oesophageal reflux disease? Gut, 1998, Volume: 43 Suppl 1 Topics: Anti-Ulcer Agents; Barrett Esophagus; Duodenal Ulcer; Gastroesophageal Reflux; Helicobacter Infectio	1998
Omerprazole and other proton pump inhibitors: pharmacology, efficacy, and safety, with special reference to use in children. Journal of pediatric gastroenterology and nutrition, 1998, Volume: 27, Issue:5 Topics: Barrett Esophagus; Child; Enzyme Inhibitors; Esophagitis; Humans; Lung Diseases; Omeprazole; Peptic	1998
Gastro-oesophageal reflux and Helicobacter pylori. Italian journal of gastroenterology and hepatology, 1998, Volume: 30 Suppl 3 Topics: Adenocarcinoma; Anti-Ulcer Agents; Barrett Esophagus; Diagnosis, Differential; Esophageal Neoplasms;	1998
Review article: Helicobacter pylori and gastro-oesophageal reflux disease-clinical implications and management. Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:2 Topics: Barrett Esophagus; Gastritis, Atrophic; Gastroesophageal Reflux; Helicobacter Infections; Helicobact	1999
Gastroesophageal reflux: practical management of a common, challenging disorder. Clinical cornerstone, 1999, Volume: 1, Issue:5 Topics: Anti-Ulcer Agents; Barrett Esophagus; Cisapride; Endoscopy, Gastrointestinal; Gastrins; Gastroesopha	1999
[Conservative and surgical antireflux therapy as prevention of carcinoma]. Zentralblatt fur Chirurgie, 2000, Volume: 125, Issue:5 Topics: Adenocarcinoma; Anti-Ulcer Agents; Barrett Esophagus; Biopsy; Clinical Trials as Topic; Esophageal N	2000
Acid suppression therapy in Barrett's esophagus: the importance of pH monitoring. Current gastroenterology reports, 2000, Volume: 2, Issue:3 Topics: Anti-Ulcer Agents; Barrett Esophagus; Gastric Acid; Gastroesophageal Reflux; Humans; Hydrogen-Ion Co	2000
Aggressive acid control: minimizing progression of Barrett's esophagus. The American journal of managed care, 2001, Volume: 7, Issue:1 Suppl Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Barrett Esophagus; Enzyme Inhibitors; Gastroesophageal Refl	2001
Gastroesophageal reflux disease and Barrett's esophagus. Endoscopy, 2001, Volume: 33, Issue:2 Topics: Adenocarcinoma; Barrett Esophagus; Endoscopy, Gastrointestinal; Esophageal Neoplasms; Esophagus; Gas	2001
Pharmacologic management of gastroesophageal reflux disease. Current gastroenterology reports, 2002, Volume: 4, Issue:3 Topics: Barrett Esophagus; Esomeprazole; Esophagitis; Female; Gastroesophageal Reflux; Humans; Omeprazole; P	2002
Acid suppression in the long-term treatment of peptic stricture and Barrett's oesophagus. Digestion, 1992, Volume: 51 Suppl 1 Topics: Barrett Esophagus; Dilatation; Esophageal Stenosis; Gastric Acid; Gastric Acidity Determination; Gas	1992

Article	Year
Argon plasma coagulation for Barrett's esophagus with low-grade dysplasia: a randomized trial with long-term follow-up on the impact of power setting and proton pump inhibitor dose. Endoscopy, 2021, Volume: 53, Issue:2 Topics: Argon Plasma Coagulation; Barrett Esophagus; Esophageal Neoplasms; Follow-Up Studies; Humans; Omepra	2021
Once-daily omeprazole/sodium bicarbonate heals severe refractory reflux esophagitis with morning or nighttime dosing. Digestive diseases and sciences, 2015, Volume: 60, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Barrett Esophagus; Comorbidity; Drug Combinations; Endoscopy, Digest	2015
One year treatment of Barrett's oesophagus with proton pump inhibitors (a multi-center study). Acta clinica Belgica, 2015, Volume: 70, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Barrett Esophagus; Epithelial Cells; Esophagoscopy; Esophag	2015
Effects of omeprazole or anti-reflux surgery on lower oesophageal sphincter characteristics and oesophageal acid exposure over 10 years. Scandinavian journal of gastroenterology, 2017, Volume: 52, Issue:1 Topics: Aged; Barrett Esophagus; Esophageal Sphincter, Lower; Europe; Female; Follow-Up Studies; Gastroesoph	2017
Squamous overgrowth is not a safety concern for photodynamic therapy for Barrett's esophagus with high-grade dysplasia. Gastroenterology, 2009, Volume: 136, Issue:1 Topics: Aged; Barrett Esophagus; Biopsy; Dihematoporphyrin Ether; Esophagus; Female; Humans; Male; Middle Ag	2009
[Drug UDCA (Ursosan) in therapeutic management of patients Barrett's esophagus]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2010, Issue:12 Topics: Age Factors; Aged; Anti-Ulcer Agents; Barrett Esophagus; Cholagogues and Choleretics; Female; Follow	2010
Long-term follow-up and factors predictive of recurrence in Barrett's esophagus treated by argon plasma coagulation and acid suppression. Endoscopy, 2002, Volume: 34, Issue:12 Topics: Adult; Aged; Anti-Ulcer Agents; Barrett Esophagus; Esophagoscopy; Female; Follow-Up Studies; Humans;	2002
Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett's esophagus. Annals of surgery, 2003, Volume: 237, Issue:3 Topics: Adenocarcinoma; Adolescent; Adult; Aged; Anti-Ulcer Agents; Barrett Esophagus; Child; Esophageal Neo	2003
Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett's esophagus. Gastrointestinal endoscopy, 2005, Volume: 61, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Argon; Barrett Esophagus; Benzimidazoles; Combined Modality	2005
Normalization of oesophageal pH does not guarantee control of duodenogastro-oesophageal reflux in Barrett's oesophagus. Alimentary pharmacology & therapeutics, 2005, Apr-15, Volume: 21, Issue:8 Topics: Aged; Anti-Ulcer Agents; Barrett Esophagus; Duodenal Diseases; Esophagoscopy; Esophagus; Female; Gas	2005
Control of intra-oesophageal and intra-gastric pH with proton pump inhibitors in patients with Barrett's oesophagus. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2005, Volume: 37, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Barrett Esophagus; Benzimidazoles; Esophageal pH Moni	2005
Lack of predictors of normalization of oesophageal acid exposure in Barrett's oesophagus. Alimentary pharmacology & therapeutics, 2005, Oct-01, Volume: 22, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Barrett	2005
Efficacy of Nissen fundoplication versus medical therapy in the regression of low-grade dysplasia in patients with Barrett esophagus: a prospective study. Annals of surgery, 2006, Volume: 243, Issue:1 Topics: Adult; Aged; Barrett Esophagus; Disease Progression; Enzyme Inhibitors; Esophagus; Female; Fundoplic	2006
Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia. Gastrointestinal endoscopy, 2007, Volume: 66, Issue:3 Topics: Adenocarcinoma; Aged; Anti-Ulcer Agents; Barrett Esophagus; Biopsy; Combined Modality Therapy; Dihem	2007
Effect of up to 3 years of high-dose lansoprazole on Barrett's esophagus. The American journal of gastroenterology, 1994, Volume: 89, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Barrett Esophagus; Epitheli	1994
Long term continuous omeprazole treatment of patients with Barrett's oesophagus. Alimentary pharmacology & therapeutics, 1995, Volume: 9, Issue:4 Topics: Adult; Aged; Barrett Esophagus; Female; Follow-Up Studies; Histamine H2 Antagonists; Humans; Male; M	1995
Failure of Nd-YAG photocoagulation therapy as treatment for Barrett's oesophagus--a pilot study. European journal of gastroenterology & hepatology, 1996, Volume: 8, Issue:7 Topics: Adult; Aged; Anti-Ulcer Agents; Barrett Esophagus; Combined Modality Therapy; Esophagoscopy; Esophag	1996
Lansoprazole heals erosive reflux oesophagitis in patients with Barrett's oesophagus. Alimentary pharmacology & therapeutics, 1997, Volume: 11, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Barrett Esophagus; Double-Blind Method; Enzyme Inhibitors;	1997
Continuous treatment with omeprazole 20 mg daily for up to 6 years in Barrett's oesophagus. Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Barrett Esophagus; Epithelium; Female; Humans; Ma	1998
Effect of omeprazole 20 mg twice daily on duodenogastric and gastro-oesophageal bile reflux in Barrett's oesophagus. Gut, 1998, Volume: 43, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Barrett Esophagus; Bile Reflux; Bilirubin; Drug A	1998
KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus. Gastrointestinal endoscopy, 1999, Volume: 49, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Barrett Esophagus; Esophageal Neo	1999
The influence of Helicobacter pylori on oesophageal acid exposure in GERD during acid suppressive therapy. Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:7 Topics: Adult; Aged; Barrett Esophagus; Double-Blind Method; Esophagus; Female; Gastroesophageal Reflux; Hel	1999
Endoscopic regression of Barrett's oesophagus during omeprazole treatment; a randomised double blind study. Gut, 1999, Volume: 45, Issue:4 Topics: Adult; Aged; Anti-Ulcer Agents; Barrett Esophagus; Double-Blind Method; Esophagoscopy; Female; Follo	1999
Ablation of Barrett's epithelium by endoscopic argon plasma coagulation in combination with high-dose omeprazole. Gastrointestinal endoscopy, 2000, Volume: 51, Issue:6 Topics: Adult; Aged; Anti-Ulcer Agents; Barrett Esophagus; Female; Follow-Up Studies; Humans; Laser Coagulat	2000
High power setting argon plasma coagulation for the eradication of Barrett's esophagus. The American journal of gastroenterology, 2000, Volume: 95, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Argon; Barrett Esophagus; Combined Modality Thera	2000
Effect of omeprazole on antral duodenogastric reflux in Barrett oesophagus. Scandinavian journal of gastroenterology, 2000, Volume: 35, Issue:8 Topics: Adolescent; Adult; Aged; Barrett Esophagus; Bilirubin; Duodenogastric Reflux; Endoscopy, Gastrointes	2000
Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trial. Gut, 2000, Volume: 47, Issue:5 Topics: Adult; Aged; Aminolevulinic Acid; Anti-Ulcer Agents; Barrett Esophagus; Double-Blind Method; Drug Th	2000
The economic impact of the diagnosis of dysplasia in Barrett's esophagus. The American journal of gastroenterology, 2000, Volume: 95, Issue:10 Topics: Anti-Ulcer Agents; Barrett Esophagus; Biopsy; Cost-Benefit Analysis; Esophageal Neoplasms; Esophagos	2000
Effects of long-term treatment with proton pump inhibitors in gastro-oesophageal reflux disease on the histological findings in the lower oesophagus. Scandinavian journal of gastroenterology, 2000, Volume: 35, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Barrett Esophagus; Double-Blind Method;	2000
Effect of elimination of acid reflux on epithelial cell proliferative activity of Barrett esophagus. Scandinavian journal of gastroenterology, 2000, Volume: 35, Issue:12 Topics: Adult; Aged; Barrett Esophagus; Biopsy; Cell Division; Double-Blind Method; Enzyme Inhibitors; Gastr	2000
Maximal acid reflux control for Barrett's oesophagus: feasible and effective. Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Barrett Esophagus; Endoscop	2001
Impact of esophageal acid exposure on the endoscopic reversal of Barrett's esophagus. The American journal of gastroenterology, 2002, Volume: 97, Issue:2 Topics: Adult; Aged; Barrett Esophagus; Combined Modality Therapy; Drug Administration Schedule; Electrocoag	2002
Omeprazole in the long-term treatment of severe gastro-oesophageal reflux disease in patients with systemic sclerosis. Alimentary pharmacology & therapeutics, 1992, Volume: 6, Issue:5 Topics: Adult; Aged; Barrett Esophagus; Drug Administration Schedule; Esophageal Motility Disorders; Esophag	1992
Comparison of omeprazole and ranitidine in treatment of refractory gastroesophageal reflux disease in patients with gastric acid hypersecretion. Digestive diseases and sciences, 1992, Volume: 37, Issue:6 Topics: Barrett Esophagus; Drug Administration Schedule; Esophagitis, Peptic; Female; Gastric Acid; Gastroes	1992

Article	Year
Laparoscopic total fundoplication is superior to medical treatment for reducing the cancer risk in Barrett's esophagus: a long-term analysis. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 2022, Nov-15, Volume: 35, Issue:11 Topics: Adenocarcinoma; Barrett Esophagus; Esophageal Neoplasms; Fundoplication; Humans; Laparoscopy; Omepra	2022
Acid suppression medications reduce risk of oesophageal adenocarcinoma in Barrett's oesophagus: a nested case-control study in US male veterans. Alimentary pharmacology & therapeutics, 2018, Volume: 48, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Barrett Esophagus; Case-Contro	2018
Omeprazole prevents CDX2 and SOX9 expression by inhibiting hedgehog signaling in Barrett's esophagus cells. Clinical science (London, England : 1979), 2019, 02-14, Volume: 133, Issue:3 Topics: Adenocarcinoma; Antineoplastic Agents; Barrett Esophagus; CDX2 Transcription Factor; Cell Line, Tumo	2019
The dose of omeprazole required to achieve adequate intraesophageal acid suppression in patients with gastroesophageal junction specialized intestinal metaplasia and Barrett's esophagus. Digestive diseases and sciences, 2013, Volume: 58, Issue:8 Topics: Anti-Ulcer Agents; Barrett Esophagus; Dose-Response Relationship, Drug; Esophagogastric Junction; Ga	2013
Effect of Roux-en-Y surgery and medical intervention on Barrett's-type changes: an in vivo model. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 2008, Volume: 21, Issue:8 Topics: Anastomosis, Roux-en-Y; Animals; Barrett Esophagus; Disease Models, Animal; Gastroesophageal Reflux;	2008
PPI-delayed diagnosis of gastrinoma: oncologic victim of pharmacologic success. Pathology oncology research : POR, 2010, Volume: 16, Issue:1 Topics: Anti-Ulcer Agents; Appendectomy; Barrett Esophagus; Delayed Diagnosis; Gastrinoma; Gastroesophageal	2010
Aspirin in the primary prevention of vascular disease. Lancet (London, England), 2009, Sep-12, Volume: 374, Issue:9693 Topics: Anti-Ulcer Agents; Aspirin; Barrett Esophagus; Drug Therapy, Combination; Evidence-Based Medicine; H	2009
Case reports--resolution of Barrett's disease and esophageal epithelial atypia after gastric bypass and LAP-BAND. Obesity surgery, 2009, Volume: 19, Issue:11 Topics: Anti-Ulcer Agents; Barrett Esophagus; Esophagitis; Esophagoscopy; Gastrectomy; Gastric Bypass; Gastr	2009
"War and Peace" with Barrett's esophagus. Digestive diseases and sciences, 2011, Volume: 56, Issue:4 Topics: Adenocarcinoma; Aged; Anti-Ulcer Agents; Antihypertensive Agents; Aspirin; Barrett Esophagus; Celeco	2011
Control of intra-oesophageal pH in patients with Barrett's oesophagus on omeprazole-sodium bicarbonate therapy. Alimentary pharmacology & therapeutics, 2012, Volume: 35, Issue:7 Topics: Aged; Barrett Esophagus; Body Mass Index; Cohort Studies; Female; Gastroesophageal Reflux; Humans; H	2012
Is 325 mg of prevention worth a pound of cure? Gastroenterology, 2012, Volume: 143, Issue:4 Topics: Aspirin; Barrett Esophagus; Cyclooxygenase Inhibitors; Dinoprostone; Female; Humans; Male; Omeprazol	2012
Efficacy and one year follow up of argon plasma coagulation therapy for ablation of Barrett's oesophagus: factors determining persistence and recurrence of Barrett's epithelium. Gut, 2002, Volume: 51, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Barrett Esophagus; Bile Reflux; Esophagus; Follow-Up Studies; Humans	2002
Persistent acid reflux and symptoms in patients with Barrett's oesophagus on proton-pump inhibitor therapy. European journal of gastroenterology & hepatology, 2002, Volume: 14, Issue:11 Topics: Adult; Aged; Anti-Ulcer Agents; Barrett Esophagus; Cohort Studies; Female; Gastroesophageal Reflux;	2002
Ablative mucosectomy is the procedure of choice to prevent Barrett's cancer. Gut, 2003, Volume: 52, Issue:1 Topics: Adenocarcinoma; Anti-Ulcer Agents; Barrett Esophagus; Catheter Ablation; Esophageal Neoplasms; Esoph	2003
Does chemoprevention of Barrett's esophagus using acid suppression and/or COX-2 inhibition prevent neoplastic progression? Reviews in gastroenterological disorders, 2002, Volume: 2 Suppl 2 Topics: Adenocarcinoma; Anti-Ulcer Agents; Barrett Esophagus; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors;	2002
Eradication of dysplastic Barrett's oesophagus using photodynamic therapy: long-term follow-up. Endoscopy, 2003, Volume: 35, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Anti-Ulcer Agents; Barrett Esophagus; Esophagos	2003
Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results. Gastrointestinal endoscopy, 2003, Volume: 58, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Barrett Esophagus; Esophageal Neo	2003
Minimal surgery for treatment of GERD. The Medical letter on drugs and therapeutics, 2003, Sep-01, Volume: 45, Issue:1164 Topics: Barrett Esophagus; Combined Modality Therapy; Enzyme Inhibitors; Fundoplication; Gastroesophageal Re	2003
[Heartburn without esophagitis. Symptoms more important than the finding?]. MMW Fortschritte der Medizin, 2003, Sep-25, Volume: 145, Issue:39 Topics: Androstadienes; Antacids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ul	2003
Persistent acid and bile reflux in asymptomatic patients with Barrett esophagus receiving proton pump inhibitor therapy. Archives of surgery (Chicago, Ill. : 1960), 2004, Volume: 139, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2004
Re: Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus. Journal of the National Cancer Institute, 2004, Jun-02, Volume: 96, Issue:11 Topics: Adenocarcinoma; Adult; Aged; Anti-Ulcer Agents; Aspirin; Barrett Esophagus; Cost-Benefit Analysis; D	2004
[The best strategies against reflux disease. Acid stomach and the sequelae]. MMW Fortschritte der Medizin, 2004, Oct-28, Volume: 146, Issue:44 Topics: Anti-Ulcer Agents; Barrett Esophagus; Chest Pain; Esophagitis; Gastroesophageal Reflux; Helicobacter	2004
Changes in gastric ECL cells and parietal cells after long-term administration of high-dose omeprazole to patients with Barrett's esophagus. The Tokai journal of experimental and clinical medicine, 2005, Volume: 30, Issue:2 Topics: Anti-Ulcer Agents; Barrett Esophagus; Cell Count; Dose-Response Relationship, Drug; Enterochromaffin	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Cryoablation of Barrett's esophagus: a pilot study. Gastrointestinal endoscopy, 2005, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles;	2005
Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence. Alimentary pharmacology & therapeutics, 2006, Mar-15, Volume: 23, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Barrett Eso	2006
Porfimer: new drug. Endobrachyesophagus: encouraging preliminary results. Prescrire international, 2006, Volume: 15, Issue:82 Topics: Barrett Esophagus; Clinical Trials as Topic; Dihematoporphyrin Ether; Disease Progression; Humans; O	2006
Porfimer sodium photodynamic therapy for management of Barrett's esophagus with high-grade dysplasia. Lasers in surgery and medicine, 2006, Volume: 38, Issue:5 Topics: Anti-Ulcer Agents; Barrett Esophagus; Catheter Ablation; Dihematoporphyrin Ether; Esophageal Neoplas	2006
A 59-year-old woman with gastroesophageal reflux disease and barrett esophagus, 4 years later. JAMA, 2006, Nov-01, Volume: 296, Issue:17 Topics: Barrett Esophagus; Enzyme Inhibitors; Esophagoscopy; Female; Gastroesophageal Reflux; Humans; Middle	2006
Banding without resection (endoscopic mucosal ligation) as a novel approach for the ablation of short-segment Barrett's epithelium: results of a pilot study. The American journal of gastroenterology, 2007, Volume: 102, Issue:8 Topics: Adult; Anti-Ulcer Agents; Barrett Esophagus; Esophagoscopy; Female; Follow-Up Studies; Humans; Ligat	2007
Argon plasma coagulation for non-dysplastic Barrett's epithelium: a hard act to follow. The American journal of gastroenterology, 2007, Volume: 102, Issue:5 Topics: Adult; Aged; Anti-Ulcer Agents; Argon; Barrett Esophagus; Combined Modality Therapy; Esophagoscopy;	2007
Getting categorical on GERD. The American journal of gastroenterology, 2007, Volume: 102, Issue:5 Topics: Anti-Ulcer Agents; Barrett Esophagus; Disease Progression; Esophageal Neoplasms; Esophagitis; Esopha	2007
Combined endoscopic thermal electrocoagulation with high dose omeprazole therapy in complicated heterotopic gastric mucosa of the esophagus. The American journal of gastroenterology, 1995, Volume: 90, Issue:11 Topics: Adult; Anti-Ulcer Agents; Barrett Esophagus; Combined Modality Therapy; Deglutition Disorders; Elect	1995
Initial results using low-dose photodynamic therapy in the treatment of Barrett's esophagus. Gastrointestinal endoscopy, 1995, Volume: 42, Issue:1 Topics: Aged; Anti-Ulcer Agents; Barrett Esophagus; Biopsy; Esophagus; Female; Hematoporphyrin Derivative; H	1995
Barrett's esophagus: photodynamic therapy for ablation of dysplasia, reduction of specialized mucosa, and treatment of superficial esophageal cancer. Gastrointestinal endoscopy, 1995, Volume: 42, Issue:1 Topics: Adenocarcinoma; Aged; Anti-Ulcer Agents; Antineoplastic Agents; Barrett Esophagus; Biopsy; Esophagea	1995
Repeat laser therapy of recurrent Barrett's epithelium: success with anacidity. Gastrointestinal endoscopy, 1995, Volume: 41, Issue:3 Topics: Barrett Esophagus; Combined Modality Therapy; Esophagus; Follow-Up Studies; Gastric Acidity Determin	1995
Treatment of pyrosis does not insure adequate control of gastric acid reflux. The American journal of gastroenterology, 1995, Volume: 90, Issue:4 Topics: Barrett Esophagus; Chronic Disease; Esophagitis; Gastroesophageal Reflux; Heartburn; Humans; Hydroge	1995
[Partial regression of Barret esophagus with high grade dysplasia and adenocarcinoma after photocoagulation and endocurietherapy under antisecretory treatment]. Gastroenterologie clinique et biologique, 1995, Volume: 19, Issue:1 Topics: Adenocarcinoma; Barrett Esophagus; Brachytherapy; Combined Modality Therapy; Endoscopy, Digestive Sy	1995
Once or twice daily doses of proton pump inhibitor in treating Barrett's esophagus? The American journal of gastroenterology, 1995, Volume: 90, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Barrett Esophagus; Drug Administration S	1995
Clinical trial of omeprazole in patients with Barrett's oesophagus. Alimentary pharmacology & therapeutics, 1994, Volume: 8, Issue:4 Topics: Barrett Esophagus; Clinical Trials as Topic; Humans; Omeprazole	1994
Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus. The American journal of gastroenterology, 1994, Volume: 89, Issue:7 Topics: Aged; Barrett Esophagus; Esophagus; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Mal	1994
Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety. Annals of internal medicine, 1994, Aug-01, Volume: 121, Issue:3 Topics: Barrett Esophagus; Drug Resistance; Esophagitis, Peptic; Female; Gastrins; Gastroscopy; Humans; Life	1994
Regression of columnar lined (Barrett's) oesophagus with continuous omeprazole therapy. Alimentary pharmacology & therapeutics, 1993, Volume: 7, Issue:6 Topics: Adult; Aged; Barrett Esophagus; Biopsy; Esophagoscopy; Esophagus; Female; Humans; Male; Microscopy,	1993
Regression of Barrett's esophagus by laser ablation in an anacid environment. Digestive diseases and sciences, 1993, Volume: 38, Issue:2 Topics: Aged; Barrett Esophagus; Biopsy; Combined Modality Therapy; Esophagoscopy; Esophagus; Humans; Laser	1993
Restoration of squamous mucosa after ablation of Barrett's esophageal epithelium. Gastroenterology, 1993, Volume: 104, Issue:6 Topics: Adult; Aged; Barrett Esophagus; Biopsy; Epithelium; Esophagus; Humans; Laser Therapy; Male; Middle A	1993
Esophageal adenocarcinoma associated with Barrett's esophagus: long-term management with laser ablation. The American journal of gastroenterology, 1995, Volume: 90, Issue:12 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Barrett Esophagus; Endoscopy; Esophageal Neoplasms; Esophag	1995
Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life. Gut, 1996, Volume: 38, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antacids; Barrett Esophagus; Cisapride; Deglutition Disorders; Disea	1996
Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life. Gut, 1996, Volume: 38, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antacids; Barrett Esophagus; Cisapride; Deglutition Disorders; Disea	1996
Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life. Gut, 1996, Volume: 38, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antacids; Barrett Esophagus; Cisapride; Deglutition Disorders; Disea	1996
Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life. Gut, 1996, Volume: 38, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antacids; Barrett Esophagus; Cisapride; Deglutition Disorders; Disea	1996
Photodynamic therapy for Barrett's esophagus: clinical update. The American journal of gastroenterology, 1996, Volume: 91, Issue:9 Topics: Adenocarcinoma; Adenoma, Villous; Anti-Ulcer Agents; Barrett Esophagus; Biopsy; Esophageal Neoplasms	1996
Epigastric pain unrelieved by omeprazole. Journal of the Tennessee Medical Association, 1996, Volume: 89, Issue:3 Topics: Abdominal Pain; Adult; Anti-Ulcer Agents; Barrett Esophagus; Diagnosis, Differential; Gastroesophage	1996
Barrett's ulcer: the clinical significance today. The American journal of gastroenterology, 1996, Volume: 91, Issue:11 Topics: Anti-Ulcer Agents; Barrett Esophagus; Esophagus; Female; Follow-Up Studies; Helicobacter Infections;	1996
Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: preliminary results. Gastrointestinal endoscopy, 1996, Volume: 44, Issue:5 Topics: Aged; Anti-Ulcer Agents; Barrett Esophagus; Combined Modality Therapy; Electrocoagulation; Epitheliu	1996
A new method of endoscopic treatment for Barrett's esophagus. Gastrointestinal endoscopy, 1996, Volume: 44, Issue:5 Topics: Anti-Ulcer Agents; Barrett Esophagus; Costs and Cost Analysis; Humans; Laser Coagulation; Mucous Mem	1996
Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole. Gastrointestinal endoscopy, 1996, Volume: 44, Issue:6 Topics: Anti-Ulcer Agents; Barrett Esophagus; Case-Control Studies; Drug Administration Schedule; Esophagosc	1996
Omeprazole and Barrett's regression: is asymptomatic good enough? The American journal of gastroenterology, 1997, Volume: 92, Issue:1 Topics: Barrett Esophagus; Histamine H2 Antagonists; Humans; Omeprazole; Time Factors; Treatment Outcome	1997
Therapeutic potential of NSAIDs and omeprazole in the oesophagus. Scandinavian journal of gastroenterology, 1997, Volume: 32, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Barrett Esophagus; Drug Therapy, Combina	1997
Barrett's esophagus: acid suppression, but no regression. The American journal of gastroenterology, 1997, Volume: 92, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Barrett Esophagus; Gastric Acid; Humans;	1997
Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus. The American journal of gastroenterology, 1997, Volume: 92, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Anti-Ulcer Agents; Barrett Esophag	1997
Medical treatment of gastroesophageal reflux disease does not prevent the development of Barrett's metaplasia and poor esophageal body motility. Langenbecks Archiv fur Chirurgie, 1997, Volume: 382, Issue:2 Topics: Anti-Ulcer Agents; Barrett Esophagus; Dose-Response Relationship, Drug; Esophageal Motility Disorder	1997
Increased esophageal chemoreceptor sensitivity to acid in patients after successful reversal of Barrett's esophagus. Digestive diseases and sciences, 1997, Volume: 42, Issue:9 Topics: Anti-Ulcer Agents; Barrett Esophagus; Case-Control Studies; Chemoreceptor Cells; Combined Modality T	1997
Fundic gland polyps developing during omeprazole therapy. The American journal of gastroenterology, 1997, Volume: 92, Issue:10 Topics: Adult; Anti-Ulcer Agents; Barrett Esophagus; Female; Gastric Fundus; Humans; Male; Middle Aged; Omep	1997
Acid control and regression of Barrett's esophagus: is the glass half full or half empty? The American journal of gastroenterology, 1997, Volume: 92, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Barrett Esophagus; Circadian Rhythm; Dru	1997
Brush cytology in the diagnosis of neoplasia in Barrett's esophagus. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 1997, Volume: 10, Issue:4 Topics: Adenocarcinoma; Anti-Ulcer Agents; Barrett Esophagus; Biopsy; Cell Count; Cell Nucleus; Chromatin; C	1997
Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal acid reflux in patients with Barrett's esophagus. The American journal of gastroenterology, 1998, Volume: 93, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Barrett Esophagus; Esophagus; Fema	1998
Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: immediate and mid term results. Gut, 1998, Volume: 43, Issue:6 Topics: Adult; Antacids; Anti-Ulcer Agents; Argon; Barrett Esophagus; Combined Modality Therapy; Electrocoag	1998
The utility of endoscopy in the management of patients with gastroesophageal reflux symptoms. The American journal of gastroenterology, 1998, Volume: 93, Issue:12 Topics: Adolescent; Adult; Aged; Barrett Esophagus; Esophagoscopy; Evaluation Studies as Topic; Female; Gast	1998
Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. Gastrointestinal endoscopy, 1999, Volume: 49, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Antineoplastic Agents; Barrett Es	1999
Laser and multipolar electrocoagulation ablation of early Barrett's adenocarcinoma: long-term follow-up. Gastrointestinal endoscopy, 1999, Volume: 49, Issue:4 Pt 1 Topics: Adenocarcinoma; Aged; Anti-Ulcer Agents; Barrett Esophagus; Electrocoagulation; Esophageal Neoplasms	1999
The efficacy and safety of argon plasma coagulation therapy in Barrett's esophagus. Gastrointestinal endoscopy, 1999, Volume: 50, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Barrett Esophagus; Biopsy; Endoscopes; E	1999
Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression. Gastroenterology, 1999, Volume: 117, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Barrett	1999
Durability of new squamous epithelium after endoscopic reversal of Barrett's esophagus. Gastrointestinal endoscopy, 1999, Volume: 50, Issue:2 Topics: Aged; Anti-Ulcer Agents; Barrett Esophagus; Biopsy; Combined Modality Therapy; Electrocoagulation; E	1999
Regression of columnar-lined (Barrett's) oesophagus with omeprazole 40 mg daily: results of 5 years of continuous therapy. Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:9 Topics: Aged; Anti-Ulcer Agents; Barrett Esophagus; Drug Administration Schedule; Endoscopy, Gastrointestina	1999
Biomarker studies in reversed Barrett's esophagus. The American journal of gastroenterology, 1999, Volume: 94, Issue:10 Topics: Aged; Aged, 80 and over; Barrett Esophagus; Biomarkers, Tumor; Biopsy; Electrocoagulation; Epitheliu	1999
[Treatment of Barrett esophagus with argon plasma coagulation with acid suppression--a prospective study]. Zeitschrift fur Gastroenterologie, 1999, Volume: 37, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Barrett Esophagus; Combined	1999
24-h pH monitoring is necessary to assess acid reflux suppression in patients with Barrett's oesophagus undergoing treatment with proton pump inhibitors. The British journal of surgery, 1999, Volume: 86, Issue:11 Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Barrett Esophagus; Child; Enzyme Inhibitors; Female; Gas	1999
Importance of adequate acid suppression in the management of Barrett's esophagus. Gastroenterology, 1999, Volume: 117, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Barrett Esophagus; Carrier Proteins; Cel	1999
Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: immediate and mid term results. Gastrointestinal endoscopy, 1999, Volume: 50, Issue:6 Topics: Anti-Ulcer Agents; Barrett Esophagus; Combined Modality Therapy; Endoscopy; Esophagus; Follow-Up Stu	1999
Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett's oesophagus. Gut, 2000, Volume: 46, Issue:4 Topics: Adenocarcinoma; Aged; Anti-Ulcer Agents; Barrett Esophagus; Esophageal Neoplasms; Esophagus; Humans;	2000
Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa. Gastroenterology, 2000, Volume: 118, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Barrett Esophagus; Child; Drug Resist	2000
Failure of oesophageal acid control in candidates for Barrett's oesophagus reversal on a very high dose of proton pump inhibitor. Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:5 Topics: Adult; Age Factors; Aged; Anti-Ulcer Agents; Barrett Esophagus; Drug Resistance; Esophagus; Female;	2000
Long-term safety and efficacy of omeprazole in gastro-oesophageal reflux disease. Lancet (London, England), 2000, Aug-19, Volume: 356, Issue:9230 Topics: Anti-Ulcer Agents; Barrett Esophagus; Drug Administration Schedule; Esophageal Neoplasms; Esophagiti	2000
The prescribing of acid suppressants prior to the endoscopic diagnosis of Barrett's oesophagus and oesophagitis. Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:2 Topics: Antacids; Barrett Esophagus; Cimetidine; Drug Prescriptions; Endoscopy; Esophagitis; Female; Humans;	2001
Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy. The American journal of gastroenterology, 2001, Volume: 96, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Barrett Esophagus; Benzimidazoles; Bile Reflux; Case-Contro	2001
Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study. Gastrointestinal endoscopy, 2001, Volume: 53, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Barrett Esophagus; Electrocoagulation; Endoscopy,	2001
Preferential repair by squamous epithelium of thermal induced injury to the proximal stomach in patients undergoing ablation of Barrett's esophagus. Gastrointestinal endoscopy, 2001, Volume: 53, Issue:7 Topics: Adult; Aged; Barrett Esophagus; Biopsy, Needle; Burns; Catheter Ablation; Electrocoagulation; Epithe	2001
Pathological documentation of complete elimination of Barrett's metaplasia following endoscopic multipolar electrocoagulation therapy. Gut, 2001, Volume: 49, Issue:1 Topics: Adult; Anti-Ulcer Agents; Barrett Esophagus; Chemotherapy, Adjuvant; Electrocoagulation; Esophagecto	2001
Follow-up of Barrett's epithelium after ablation by endoscopic argon plasma coagulation. Gastrointestinal endoscopy, 2001, Volume: 54, Issue:1 Topics: Barrett Esophagus; Combined Modality Therapy; Esophagoscopy; Follow-Up Studies; Humans; Laser Coagul	2001
Efficacy of medical therapy and antireflux surgery to prevent Barrett's metaplasia in patients with gastroesophageal reflux disease. Annals of surgery, 2001, Volume: 234, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimid	2001
Effect of multipolar electrocoagulation on EUS findings in Barrett's esophagus. Gastrointestinal endoscopy, 2002, Volume: 55, Issue:1 Topics: Barrett Esophagus; Electrocoagulation; Endosonography; Epithelium; Esophagoscopy; Esophagus; Female;	2002
Drug points: Severe myalgia from an interaction between treatments with pantoprazole and methotrexate. BMJ (Clinical research ed.), 2002, Jun-22, Volume: 324, Issue:7352 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Barrett Esophagus; Benzimidazoles; Dermatologic Agents; Dru	2002
[Facial pain in a thoracic disease]. Nederlands tijdschrift voor geneeskunde, 1992, Oct-10, Volume: 136, Issue:41 Topics: Aged; Aged, 80 and over; Barrett Esophagus; Facial Pain; Female; Humans; Omeprazole	1992
Criteria for use of omeprazole in adult inpatients and outpatients. Clinical pharmacy, 1992, Volume: 11, Issue:2 Topics: Adult; Barrett Esophagus; Duodenal Ulcer; Education, Pharmacy, Continuing; Esophagitis, Peptic; Huma	1992
[Barrett's esophagus and omeprazole]. Revista clinica espanola, 1991, Volume: 188, Issue:9 Topics: Barrett Esophagus; Female; Gastroesophageal Reflux; Humans; Middle Aged; Omeprazole	1991
Severe complicated oesophagitis. Scandinavian journal of gastroenterology. Supplement, 1989, Volume: 168 Topics: Barrett Esophagus; Esophagitis, Peptic; Gastric Fundus; Humans; Male; Middle Aged; Omeprazole	1989
Regression of Barrett's epithelium with omeprazole. The New England journal of medicine, 1989, Jun-01, Volume: 320, Issue:22 Topics: Aged; Barrett Esophagus; Epithelium; Esophagus; Humans; Middle Aged; Omeprazole	1989
Effect of omeprazole on gastroesophageal reflux in Barrett's esophagus. The American journal of gastroenterology, 1989, Volume: 84, Issue:10 Topics: Barrett Esophagus; Esophagitis, Peptic; Esophagogastric Junction; Female; Gastric Acidity Determinat	1989
Healing of chronic Barrett ulcers with omeprazole. The American journal of gastroenterology, 1986, Volume: 81, Issue:9 Topics: Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles; Drug Resistance; Esophageal Diseases; Es	1986
Barrett's ulcer: response to standard dose ranitidine, high dose ranitidine, and omeprazole. The American journal of gastroenterology, 1988, Volume: 83, Issue:9 Topics: Barrett Esophagus; Drug Administration Schedule; Drug Therapy, Combination; Esophageal Diseases; Eso	1988

omeprazole and Barrett Epithelium

Research Excerpts

Research

Studies (160)

Authors

Clinical Trials (20)

Trial Overview

Trial Outcomes

Depth of Injury

Side Effects of Subjects Receiving Cryospray Therapy.

Reviews

Trials

Other Studies